BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 200092)

  • 1. A study of the dose-effect relationship of cholestyramine in children with familial hypercholesterolemia.
    Farah JR; Kwiterovich PO; Neill CA
    Adv Exp Med Biol; 1977; 82():212-5. PubMed ID: 200092
    [No Abstract]   [Full Text] [Related]  

  • 2. Cholestyramine: an effective, twice-daily dosage regimen.
    Blum CB; Havlik RJ; Morganroth J
    Ann Intern Med; 1976 Sep; 85(3):287-9. PubMed ID: 183576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholestyramine for elevated serum cholesterol.
    Med Lett Drugs Ther; 1974 Apr; 16(8):33-4. PubMed ID: 4362570
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapy of familial hypercholesterolemia in childhood: diet and cholestyramine resin for 24 to 36 months.
    Glueck CJ; Tsang RC; Fallat RW; Mellies M
    Pediatrics; 1977 Mar; 59(3):433-41. PubMed ID: 840563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholestyramine in hypercholesterolaemia.
    West R; Lloyd JK
    Lancet; 1977 Feb; 1(8009):488-9. PubMed ID: 65596
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma vitamin A and E levels in children with familial type II hyperlipoproteinemia during therapy with diet and cholestyramine resin.
    Glueck CJ; Tsang RC; Fallat RW; Scheel D
    Pediatrics; 1974 Jul; 54(1):51-5. PubMed ID: 4365953
    [No Abstract]   [Full Text] [Related]  

  • 7. Pseudohomozygous type II hyperlipoproteinemia.
    Morganroth J; Levy RI; McMahon AE; Gotto AM
    J Pediatr; 1974 Nov; 85(5):639-43. PubMed ID: 4370845
    [No Abstract]   [Full Text] [Related]  

  • 8. Dose-effect relation of cholestryamine in children and young adults with familial hypercholesterolaemia.
    Farah JR; Kwiterovich PO; Neill CA
    Lancet; 1977 Jan; 1(8002):59-63. PubMed ID: 63709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experiences with the homozygous cases of familial hypercholesterolemia. A report of 52 patients.
    Khachadurian AK; Uthman SM
    Nutr Metab; 1973; 15(1):132-40. PubMed ID: 4351242
    [No Abstract]   [Full Text] [Related]  

  • 10. Familial type II hyperlipoproteinaemia. Clinical features and results of treatment in children and young adults.
    Stein EA; Mendelsohn D; Bersohn I
    S Afr Med J; 1974 Jan; 48(4):135-8. PubMed ID: 4363092
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical trials of cholestyramine alone and in combination with clofibrate in hypercholesterolemia].
    Carlson LA; Olsson AG; Orö L; Rössner S
    Lakartidningen; 1974 Sep; 71(36):3289-91. PubMed ID: 4605566
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of children with familial hypercholesterolaemia.
    West RJ; Fosbrooke AS; Lloyd JK
    Postgrad Med J; 1975; 51(8):suppl 82-7. PubMed ID: 1052928
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative efficacy and safety of pravastatin and cholestyramine alone and combined in patients with hypercholesterolemia. Pravastatin Multicenter Study Group II.
    Arch Intern Med; 1993 Jun; 153(11):1321-9. PubMed ID: 8507122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [On the treatment of hyperlipoproteinaemia type II with cholestyramine (author's transl)].
    Válek J; Pechar J; Hrubá F
    Cas Lek Cesk; 1973 Dec; 112(49):1531-4. PubMed ID: 4358602
    [No Abstract]   [Full Text] [Related]  

  • 15. [Resins in the treatment of hypercholesterolemia].
    Jacotot B
    Med Chir Dig; 1978; 7(8):697-8. PubMed ID: 745469
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hypolipidemic effect of cholestyramine in patients affected by type II hyperlipoproteinemia].
    Sauvanet JP; Drouin P; Mejean L; Lambert D; Debry G
    Therapie; 1978; 33(5):615-22. PubMed ID: 217121
    [No Abstract]   [Full Text] [Related]  

  • 17. Hypercholesterolemia: new values, new strategies.
    Lueg MC; Anding RH
    Hosp Pract (Off Ed); 1986 Jan; 21(1A):112-3, 116-7, 120-2. PubMed ID: 3080456
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparison of cholestyramine and nicotinic acid in the treatment of familial type II hyperlipoproteinaemia.
    Mann JI; Harding PA; Turner RC; Wilkinson RH
    Br J Clin Pharmacol; 1977 Jun; 4(3):305-8. PubMed ID: 197982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of hypercholesterolemia.
    Kane JP; Havel RJ
    Annu Rev Med; 1986; 37():427-35. PubMed ID: 3518611
    [No Abstract]   [Full Text] [Related]  

  • 20. Malabsorption of thyroid hormone with cholestyramine administration.
    Rosenberg R
    Conn Med; 1994 Feb; 58(2):109. PubMed ID: 8004946
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.